Quick answers
- What is Tadalafil used for?
- The FDA-approved label (Cialis, Eli Lilly and Company, June 3, 2026) says: “CIALIS ® is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of: erectile dysfunction (ED) the signs and symptoms of benign prostatic hyperplasia (BPH) ED and the signs and symptoms of BPH (ED/BPH) If CIALIS is used with finasteride to initiate BPH treatment, such use is recommended for up to 26 weeks. 1.1 Erectile Dysfunction CIALIS ® is indicated for the treatment of erectile dysfunction (ED). …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Tadalafil have a boxed warning?
- The label we quote has no boxed warning, but 1 of 136 FDA labels for this medicine do. Check the label of your own product.
- Is there a shortage of Tadalafil?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Tadalafil been recalled?
- FDA enforcement reports list 9 recalls of products of this medicine; the newest started March 23, 2023 (Class II). A recall usually concerns specific lots, not every product.
- Who makes Tadalafil?
- 50 companies list prescription products of Tadalafil in the FDA NDC Directory, including NuCare Pharmaceuticals, Inc., Bryant Ranch Prepack and Asclemed USA, Inc..
What Tadalafil is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
CIALIS ® is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of: erectile dysfunction (ED) the signs and symptoms of benign prostatic hyperplasia (BPH) ED and the signs and symptoms of BPH (ED/BPH) If CIALIS is used with finasteride to initiate BPH treatment, such use is recommended for up to 26 weeks. 1.1 Erectile Dysfunction CIALIS ® is indicated for the treatment of erectile dysfunction (ED). …
— FDA label: Cialis, Eli Lilly and Company, effective June 3, 2026. Read the full label on DailyMed →
The FDA has 136 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Conditions named on the label
These condition names appear word for word in the label’s “Indications and Usage” text (matched with a reviewed table). Each page lists hospitals whose own websites name the condition.
Related medical specialties
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
1 of 136 FDA labels for this medicine have a boxed warning.
Forms and how it is given
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| tadalafil 10 mg tablet | Generic | $0.1533 per tablet |
| tadalafil 10 mg tablet, coated | Generic | $0.1533 per tablet |
| tadalafil 10 mg tablet, film coated | Generic | $0.1533 per tablet |
| tadalafil 10 mg tablet, film coated | Brand: Cialis | $53.69 per tablet |
| tadalafil 2.5 mg tablet | Generic | $0.1203 per tablet |
| tadalafil 2.5 mg tablet, coated | Generic | $0.1203 per tablet |
| tadalafil 2.5 mg tablet, film coated | Generic | $0.1203 per tablet |
| tadalafil 20 mg tablet | Generic | $0.1448–$0.1887 per tablet 14 packages, lowest to highest |
| tadalafil 20 mg tablet, coated | Generic | $0.1887 per tablet |
| tadalafil 20 mg tablet, film coated | Generic | $0.1448–$0.1887 per tablet 24 packages, lowest to highest |
| tadalafil 20 mg tablet, film coated | Brand: Cialis | $53.76 per tablet |
| tadalafil 20 mg/5 mL suspension | Brand: Tadliq | $13.59 per mL |
| tadalafil 5 mg tablet | Generic | $0.1078 per tablet |
| tadalafil 5 mg tablet, coated | Generic | $0.1078 per tablet |
| tadalafil 5 mg tablet, film coated | Generic | $0.1078 per tablet |
| tadalafil 5 mg tablet, film coated | Brand: Cialis | $9.21 per tablet |
NADAC list of November 4, 2026; these prices took effect between March 18, 2026 and October 28, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- NuCare Pharmaceuticals, Inc.17 products
- Bryant Ranch Prepack15 products
- Asclemed USA, Inc.15 products
- Proficient Rx LP13 products
- A-S Medication Solutions11 products
- Solco Healthcare US, LLC9 products
- Aphena Pharma Solutions - Tennessee, LLC8 products
- Amneal Pharmaceuticals NY LLC8 products
- PD-Rx Pharmaceuticals, Inc.7 products
- Preferred Pharmaceuticals Inc.7 products
- Remedyrepack Inc.6 products
- Camber Pharmaceuticals, Inc.5 products
- Macleods Pharmaceuticals Limited5 products
- Dr.Reddys Laboratories Inc5 products
- Aurobindo Pharma Limited5 products
- Torrent Pharmaceuticals Limited5 products
- AvKARE5 products
- Ajanta Pharma USA Inc.5 products
- Nivagen Pharmaceuticals, Inc.4 products
- NorthStar RxLLC4 products
- Unichem Pharmaceuticals (USA), Inc.4 products
- Bostal LLC4 products
- Accord Healthcare Inc.4 products
- Burel Pharmaceuticals, LLC4 products
- Sun Pharmaceutical Industries, Inc.4 products
- Zydus Lifesciences Limited4 products
- VKT Pharma Private Limited4 products
- Fourrts (India) Laboratories Private Limited4 products
- Alembic Pharmaceuticals Limited4 products
- Umedica Laboratories USA Inc.4 products
- Alembic Pharmaceuticals Inc.4 products
- Qilu Pharmaceutical Co., Ltd.4 products
- HEC Pharm USA Inc.4 products
- NorthStar Rx LLC4 products
- Northwind Health Company, LLC4 products
- XLCare Pharmaceuticals, Inc.4 products
- Upsher-Smith Laboratories, LLC4 products
- Zydus Pharmaceuticals USA Inc.4 products
- Eli Lilly and Company3 products
- Quallent Pharmaceuticals Health LLC3 products
- Teva Pharmaceuticals, Inc.3 products
- ANI Pharmaceuticals, Inc.3 products
- Advanced Rx of Tennessee, LLC1 product
- CMP Pharma, Inc.1 product
- NuCare Pharmaceutical, Inc.1 product
- United Therapeutics Corporation1 product
- Lupin Pharmaceuticals, Inc.1 product
- Redpharm Drug1 product
- Cipla USA Inc.1 product
- Direct_Rx1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA021368 CIALIS | Lilly | November 21, 2003 | 21, latest February 15, 2018 2018: Efficacy · 2017: Labeling · 2016: Manufacturing (CMC) |
| NDA022332 ADCIRCA | Eli Lilly Co | May 22, 2009 | 6, latest September 15, 2020 2020: Labeling · 2017: Labeling · 2015: Labeling |
| NDA214522 TADLIQ | Cmp Dev LLC | June 17, 2022 | — |
Generic approvals (31)
- ANDA206286Aurobindo Pharma Ltd · February 5, 2019
- ANDA209907Hetero Labs Ltd III · February 5, 2019
- ANDA210145DR Reddys · February 5, 2019
- ANDA210255Cipla · February 5, 2019
- ANDA210392Ajanta Pharma Ltd · February 5, 2019
- ANDA210572Chartwell Rx · February 5, 2019
- ANDA204809Alembic · March 26, 2019
- ANDA206285Aurobindo Pharma Ltd · March 26, 2019
- ANDA206693Zydus Pharms · March 26, 2019
- ANDA208934Sun Pharm · March 26, 2019
- ANDA209167Accord Hlthcare · March 26, 2019
- ANDA209250Unichem · March 26, 2019
- ANDA209654Ajanta Pharma Ltd · March 26, 2019
- ANDA209744Amneal Pharms Co · March 26, 2019
- ANDA209908Hetero Labs Ltd III · March 26, 2019
- ANDA210069DR Reddys · March 26, 2019
- ANDA210420Qilu Pharm Hainan · March 26, 2019
- ANDA211335Sunshine · March 26, 2019
- ANDA211839Torrent · March 26, 2019
- ANDA212062Torrent · March 26, 2019
- ANDA205885Watson Labs Inc · March 29, 2019
- ANDA207244Macleods Pharms · October 7, 2019
- ANDA207290Macleods Pharms · October 16, 2019
- ANDA211298Umedica · October 23, 2020
- ANDA208824Hangzhou Binjiang · October 27, 2020
- ANDA215556Vkt Pharma · November 4, 2021
- ANDA210608Prinston Inc · August 11, 2022
- ANDA210609Prinston Inc · August 11, 2022
- ANDA216932Teva Pharms Inc · October 12, 2022
- ANDA215949Novitium Pharma · March 3, 2023
- ANDA217606Rising · August 13, 2024
Shortage status
The FDA drug shortage list does not show these products.
Recalls
From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
March 23, 2023 · Class II · Ongoing · D-0526-2023
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Tadalafil Tablets, USP, 20 mg, 7-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-8153-7 — Preferred Pharmaceuticals, Inc.
-
March 16, 2023 · Class II · Ongoing · D-0554-2023
CGMP Deviations
Tadalafil Tablets, USP 5 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-487-52 — Northwind Pharmaceuticals LLC
-
March 16, 2023 · Class II · Ongoing · D-0553-2023
CGMP Deviations
Tadalafil Tablets, USP 20 mg, packaged in a) 6-count bottles (NDC 51655-473-87), and b) 15-count bottles (NDC 51655-473-54), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. — Northwind Pharmaceuticals LLC
-
February 7, 2023 · Class II · Terminated · D-0416-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Tadalafil Tablets, USP 10 mg Rx Only, Packaged as: a) 30-count bottle NDC 16729-371-10, UPC 3 16729 37110 0; b) 500-count bottle NDC 16729-371-16, UPC 3 16729 37116 2; Manufactured for: Accord Healthcare, Inc., Durham, N — Accord Healthcare, Inc.
-
February 7, 2023 · Class II · Terminated · D-0414-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Tadalafil Tablets, USP, 2.5 mg Rx Only, Packaged as: a) 30-count bottle NDC 16729-369-10, UPC 3 16729 36910 7; b) 500-count bottle NDC 16729-369-16, UPC 3 16729 36916 9; Manufactured for: Accord Healthcare, Inc., Durham, — Accord Healthcare, Inc.
-
February 7, 2023 · Class II · Terminated · D-0417-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Tadalafil Tablets, USP, 20 mg, Rx Only, Packaged as: a) 30-count bottle NDC 16729-372-10, UPC 3 16729 37210 7; b) 500-count bottle NDC 16729-372-16, UPC 3 16729 37216 9; Manufactured for: Accord Healthcare, Inc., Durham, — Accord Healthcare, Inc.
-
February 7, 2023 · Class II · Terminated · D-0415-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Tadalafil Tablets, USP, 5 mg Rx Only, Packaged as: a) 30-count bottle NDC 16729-370-10, UPC 3 16729 37010 3; b) 500-count bottle NDC 16729-370-16, UPC 3 16729 37016 5; Manufactured for: Accord Healthcare, Inc., Durham, N — Accord Healthcare, Inc.
-
October 25, 2021 · Class II · Terminated · D-0231-2022
Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.
Tadalafil Tablets, USP 20 mg, 30 count bottle, Rx Only, Manufactured for: Northstar Rx LLC Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Industries Limited, India, NDC # 16714-077-01 — SUN PHARMACEUTICAL INDUSTRIES INC
-
October 25, 2021 · Class II · Terminated · D-0230-2022
Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.
Tadalafil Tablets, USP 5 mg, 30 count bottle, Rx Only, Manufactured for: Northstar Rx LLC Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Industries Limited, India, NDC # 16714-075-01 — SUN PHARMACEUTICAL INDUSTRIES INC
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Official identifiers
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Cialis, Eli Lilly and Company, effective June 3, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →